Original Research
Accepted on 20 May 2024
Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1375413
Type at least 3 characters
5,784 articles
Articles
Editorial
Accepted on 20 May 2024
Editorial: Novel immune markers and predictive models for immunotherapy and prognosis in breast and gynecological cancers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1431245
Original Research
Published on 17 May 2024
PD-1 inhibitor combined with paclitaxel and cisplatin in the treatment of recurrent and metastatic hypopharyngeal/laryngeal squamous cell carcinoma: efficacy and survival outcomes
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1353435
- 133 views
Original Research
Accepted on 16 May 2024
The causal effect of adipose tissue on Hodgkin's lymphoma: two-sample Mendelian randomization study and validation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1400756
Editorial
Accepted on 16 May 2024
Editorial: Spatiotemporal heterogeneity in CNS tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1430227
Review
Accepted on 16 May 2024
Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1416941
Original Research
Accepted on 16 May 2024
Exploitation of CD3z to enhance TCR expression levels and antigen-specific T cell function
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1386132
Original Research
Accepted on 16 May 2024
Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1412076
Original Research
Accepted on 16 May 2024
Establishment of a prognostic model for hypoxia-associated genes in OPSCC and revelation of intercellular crosstalk
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1371365
Review
Published on 16 May 2024
Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1399926
- 307 views
Editorial
Published on 16 May 2024
Editorial: Targeting key cellular signaling network for cancer chemotherapy and immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1425261
- 111 views
Review
Published on 16 May 2024
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1341079
- 208 views
Original Research
Published on 16 May 2024
Evaluating the predictive value of angiogenesis-related genes for prognosis and immunotherapy response in prostate adenocarcinoma using machine learning and experimental approaches
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1416914
- 172 views
Review
Published on 16 May 2024
The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1358668
- 205 views
Original Research
Accepted on 15 May 2024
Expression and clinical significance of interleukin-6 pathway in cholangiocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1374967
Review
Accepted on 15 May 2024
The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1400112